CDC: Fatal ODs From Rx Opioids Have Tripled in U.S.

Share this content:
CDC: Fatal ODs From Rx Opioids Have Tripled in U.S.
CDC: Fatal ODs From Rx Opioids Have Tripled in U.S.

TUESDAY, Dec. 2, 2014 (HealthDay News) -- Fatal overdoses involving opioid analgesics have tripled over the past decade, a new report shows. Deaths from heroin also nearly tripled between 1999 and 2012, according to the report released Tuesday by the U.S. Centers for Disease Control and Prevention.

In the latest report, released by the CDC's National Center for Health Statistics, researchers tracked data from the CDC's National Vital Statistics System. The study was led by Margaret Warner, Ph.D., of the CDC's Division of Vital Statistics. Her team found that, after adjusting for age, fatal overdoses involving opioid analgesics "more than tripled, from 1.4 per 100,000 in 1999 to 5.1 in 2012." The rates were higher in certain states, with Kentucky, Nevada, New Mexico, Utah, and West Virginia hardest hit. In West Virginia, 32 out of every 100,000 residents overdosed on any kind of drug -- the highest rate in the nation.

However, the rate of increase for such deaths has slowed nationwide. From 1999 through 2006, there was "an average increase of about 18 percent each year," the CDC authors write, but that has slowed since 2006. And in the last year of the study, 2011 to 2012, the CDC noted a 5 percent drop in opioid analgesic deaths, the first such decrease in more than a decade.

The researchers also found that "drug-poisoning deaths involving heroin nearly tripled, from 0.7 deaths per 100,000 in 1999 to 1.9 in 2012." And unlike the trend for opioid analgesics, the upsurge in heroin-related deaths shows no signs of slowing down. In fact, "between 2011 and 2012, the rate of drug-poisoning deaths involving heroin increased 35 percent," the CDC study authors write.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »